Sitagliptin: a review of its use in patients with type 2 diabetes mellitus
The emerging story of GLP-1 agonists and migraines is part of a larger narrative about how metabolic drugs are revealing connections between body systems that were previously studied in isolation
Recommended readings Learn more about weight management by reading our expert-reviewed articles
Who Should Not Use Tirzepatide
By prolonging the duration of SA -induced disease resistance in plants, the nanosystem enhanced various plant defense mechanisms, including reinforcement of physical barriers (lignin and suberin deposition), upregulation of antioxidant defense enzymes (POD, SOD, and CAT), the activation of defense-related genes ( OsPR1a , OsWRKY45 , OsAOS2 , and OsJAMYB ), and the stimulation of chitinase synthesis